Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review.
about
Adenoid cystic carcinoma: current therapy and potential therapeutic advances based on genomic profilingManagement of salivary gland carcinomas - a reviewAdenoid cystic carcinoma: A review of recent advances, molecular targets, and clinical trials.Aquaporin-1 promoter hypermethylation is associated with improved prognosis in salivary gland adenoid cystic carcinoma.Prognostic significance of p53 immunohistochemical expression in adenoid cystic carcinoma of the salivary glands: a meta-analysis.High expression of SOX2 is associated with poor prognosis in patients with salivary gland adenoid cystic carcinomaA phase 2 study of vorinostat in locally advanced, recurrent, or metastatic adenoid cystic carcinoma.Induction of autophagy-dependent cell death by the survivin suppressant YM155 in salivary adenoid cystic carcinomaA multicenter phase II study of everolimus in patients with progressive unresectable adenoid cystic carcinoma.EGFR inhibition prevents in vitro tumor growth of salivary adenoid cystic carcinoma.Airway compromise due to adenoid cystic carcinoma obstructing the distal trachea: a review of current management and clinical trials.Inhibition of survivin reduces HIF-1α, TGF-β1 and TFE3 in salivary adenoid cystic carcinoma.Outcomes and prognostic factors in modern era management of major salivary gland cancer.Role of hypoxia-inducible factor-1α and CD146 in epidermal growth factor receptor-mediated angiogenesis in salivary gland adenoid cystic carcinoma.Metastatic Salivary Gland Tumors: A Single-Center Study Demonstrating the Feasibility and Potential Clinical Benefit of Molecular-Profiling-Guided Therapy.MicroRNA-101-3p suppresses cell proliferation, invasion and enhances chemotherapeutic sensitivity in salivary gland adenoid cystic carcinoma by targeting Pim-1.Anti-tumor effect of inhibition of IL-6 signaling in mucoepidermoid carcinoma.Adding concurrent chemotherapy to postoperative radiotherapy improves locoregional control but Not overall survival in patients with salivary gland adenoid cystic carcinoma-a propensity score matched study.VEGF and Ki-67 Overexpression in Predicting Poor Overall Survival in Adenoid Cystic Carcinoma.Organ preservation for adenoid cystic carcinoma of the larynxSOD2 deregulation enhances migration, invasion and has poor prognosis in salivary adenoid cystic carcinomaPrioritizing phase I treatment options through preclinical testing on personalized tumorgraft.The mutational landscape of adenoid cystic carcinomaCetuximab and platinum-based chemoradio- or chemotherapy of patients with epidermal growth factor receptor expressing adenoid cystic carcinoma: a phase II trial.Autocrine epiregulin activates EGFR pathway for lung metastasis via EMT in salivary adenoid cystic carcinoma.Primary adenoid cystic carcinoma of the trachea with thyroid invasion: a case report and literature review.Risk factors and prognosis for salivary gland adenoid cystic carcinoma in southern china: A 25-year retrospective study.Down-regulation of miR-125a-5p is associated with salivary adenoid cystic carcinoma progression via targeting p38/JNK/ERK signal pathway.B7-H3 regulates migration and invasion in salivary gland adenoid cystic carcinoma via the JAK2/STAT3 signaling pathway.Recurrent salivary gland cancer.Systemic therapy in the management of metastatic or advanced salivary gland cancers.Management of salivary gland tumors.Recent trends in the management of minor salivary gland carcinoma.Adenoid cystic carcinoma of the submandibular gland with rare metastasis to the sternum in a 52-year-old male.Ongoing challenges in the treatment of adenoid cystic carcinoma of the head and neck.Radiosensitization of adenoid cystic carcinoma with MDM2 inhibition.Notch2 signaling contributes to cell growth, invasion, and migration in salivary adenoid cystic carcinoma.Slug silencing inhibited perineural invasion through regulation of EMMPRIN expression in human salivary adenoid cystic carcinoma.Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01).Inhibition of autophagy enhances cisplatin cytotoxicity in human adenoid cystic carcinoma cells of salivary glands.
P2860
Q26781643-227BC869-88AE-4716-A5B1-169D2C3C9A82Q28069083-78DFBD1C-EF2A-49EF-B617-D98EBE7D18EEQ30301145-A96C7E12-3131-41A2-95A3-688C088E8E62Q30408217-71F15E54-4992-4B50-A2F7-0A8797D3EF6BQ33710168-73A5B3D3-77FB-43B6-B63B-5248B9F6FE71Q33755780-C854EA6C-90E9-45B7-92D9-95A0176137B3Q33779308-E0738181-DEE4-407A-B34F-B4B7E9B21005Q34412375-1308D6D5-986B-4994-ADFB-5A817BB99239Q34491238-30C5206E-64C8-4917-90D5-B29E391C6B81Q34622206-1397C501-3922-4A31-A9E8-A6077C42FFB5Q35015755-976ED8B1-57F0-45DE-9D5F-2A74459926BEQ35499428-E916F7A4-0666-4717-A96F-F727676D941CQ35889915-69F8C3C2-38DB-442D-8F12-CB7E9DB07C44Q35919703-CA9EBA12-126C-42A5-8F4A-458862CD2616Q36095613-CCFAF723-AD73-4AC4-9330-2AC7F21DFB17Q36309379-AFABF396-5007-4AA4-88A0-2C666179964DQ36356086-87FFA686-2FAA-48E9-961F-2AADFF8AC712Q36714995-AAC1E1DB-4C16-420D-87C1-DA21A8485410Q36832127-23AB8E31-F826-4D4A-BB54-88B8C2FDF8BFQ36871696-F4CC9D22-741A-4C9D-A4A7-36E0307B0CE5Q36903196-D56A60D1-8229-414E-B74C-49088BC50311Q36920470-6CB520E5-1BA2-4B2C-957E-84B4634230D2Q37003447-C6C962C6-0E90-435E-9DE3-1BE03563DE5BQ37185867-970F75D4-228D-4E25-9B9E-2111CDBC9464Q37295302-3C931154-1F24-4182-A646-C7D9ACD5D638Q37344456-C34908F2-B93D-468B-A02D-75C5E5CECCFEQ37626622-8B450477-D414-417F-BE7D-3A366E3C5441Q37732988-A3DBA1FD-E28F-4FB4-A1C2-054671DEA6A9Q37733039-DAF94ADE-3972-4406-A2D2-7F212C791E9BQ37973008-6C4AD0AD-5656-48FE-A55D-5EE4B3E88F48Q38007528-4A0C3653-6976-4004-9CDE-BD22B4D80051Q38055494-D9D8A2FB-D66D-4D88-98F9-0B974AC2862BQ38096338-63B56E95-11D1-4D0F-B614-C26AD0BA9527Q38340523-BC314796-93C7-45B2-97D1-772602A2C346Q38430357-5694CFA7-07CC-4B02-84DC-B97359E7F86EQ38703939-634048D2-C706-4AED-B74A-78852E385C0BQ38830974-73480B0D-7F9F-4965-BF1A-F86A80DCF38CQ38836968-2546D23A-85A3-4BF6-AAA8-12D2F4FAC252Q39012625-006A96B7-E502-49CB-876E-80ADC4BAFBDDQ39165527-AFB3F95D-77A3-4F7B-A4BE-AD6C49CECA7B
P2860
Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Systemic therapy in the manage ...... y glands: a systematic review.
@en
Systemic therapy in the manage ...... y glands: a systematic review.
@nl
type
label
Systemic therapy in the manage ...... y glands: a systematic review.
@en
Systemic therapy in the manage ...... y glands: a systematic review.
@nl
prefLabel
Systemic therapy in the manage ...... y glands: a systematic review.
@en
Systemic therapy in the manage ...... y glands: a systematic review.
@nl
P2093
P1433
P1476
Systemic therapy in the manage ...... y glands: a systematic review.
@en
P2093
David G Pfister
Eric Sherman
Matthew G Fury
Scott A Laurie
P304
P356
10.1016/S1470-2045(10)70245-X
P577
2010-12-10T00:00:00Z